Detalhe da pesquisa
1.
A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer.
Gynecol Oncol
; 126(3): 369-74, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22659190
2.
A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group study.
Gynecol Oncol
; 124(1): 48-52, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21996263
3.
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.
J Clin Oncol
; 40(35): 4119-4128, 2022 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759733
4.
Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer.
Gynecol Oncol
; 94(2): 533-9, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15297200